Skip to main content

Impact of early enteral nutrition on children with acute pancreatitis: A systematic review and meta analysis

Journal
Journal of pediatric gastroenterology and nutrition (Q1)
Published
14 September 2026
Study design
Systematic review / meta-analysis of RCTs
Evidence level
Level 1, High (CEBM 1a)
Authors
Lufang Rao, Weiwei Zhou, Beili Zhong, Yingying Jiang, Yan Ying
PMID
42736108
DOI
10.1002/jpn3.70581

Why clinicians should know about it

  • Picked for Gastroenterology (top studies of the week, 20 September 2026): Meta-analysis of early enteral nutrition in acute pancreatitis
  • Picked for Pediatrics and Child Health (top studies of the week, 20 September 2026): Ranked by evidence level and journal quartile

Abstract

OBJECTIVE: To systematically evaluate the impact of early enteral nutrition (EEN) on children with acute pancreatitis (AP). METHODS: Randomized controlled trials (RCTs) and quasi-experimental studies investigating the effects of EEN on children with AP were retrieved from databases including China National Knowledge Infrastructure (CNKI), Wanfang, Chinese Scientific Journal Database (VIP), Chinese Biomedical Literature Database (CBM), PubMed, Cochrane Library, Embase, and Web of Science from inception to October 1, 2025. Data analysis was performed using RevMan 5.2 software. RESULTS: Nine trials involving 485 children with AP were included. The analysis revealed that the observation group (EEN) demonstrated significant improvements compared to the control group in the following outcomes: serum albumin (standardized mean difference [SMD] = 1.28, 95% confidence interval [CI] = 0.68-1.88, p < 0.0001), acute physiology and chronic health evaluation II (APACHE-II) score (SMD = -2.58, 95% CI = -4.46 to -0.70, p = 0.007), tumor necrosis factor-α (TNF-α) level (SMD = -2.23, 95% CI = -3.36 to -1.10, p = 0.0001), and incidence of adverse events (odds ratio [OR] = 0.30, 95% CI = 0.17-0.52, p < 0.0001). CONCLUSION: EEN significantly increases serum albumin levels, reduces APACHE-II scores and TNF-α levels, and decreases the incidence of adverse events in children with AP.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.